| Trial ID: | L4631 |
| Source ID: | NCT04707508
|
| Associated Drug: |
Valsartan 80 Mg And Metformin
|
| Title: |
Effect of Adding Renin-Angiotensin System Inhibitors to Standard Antidiabetic Therapy on Glycemic Control in Patients With Type 2 Diabetes Ellitus
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Valsartan 80 mg and metformin|DRUG: Metformin
|
| Outcome Measures: |
Primary: Serum glycosylated hemoglobin A1c, Change in serum glycosylated hemoglobin A1c of the participants, 24 weeks | Secondary: Plasma lipid fractions, Change in plasma triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, 24 weeks|Blood pressure, Change in systolic blood pressure and diastolic blood pressure, 24 weeks
|
| Sponsor/Collaborators: |
Sponsor: Nantou Christian Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
203
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2017-12-01
|
| Completion Date: |
2019-11-29
|
| Results First Posted: |
|
| Last Update Posted: |
2021-01-13
|
| Locations: |
Nantou Christian Hospital, Nantou City, Nantou County, 540001, Taiwan
|
| URL: |
https://clinicaltrials.gov/show/NCT04707508
|
